Pathological response and tumor regression grading following neoadjuvant chemo‑immunotherapy and chemotherapy in resectable non‑small cell lung cancer

作者
Özge Kaya,Yaren Sari Cataldas,Nazlican Barel,Mehmet Büyükevli
出处
期刊:Oncology Letters [Spandidos Publishing]
卷期号:32 (1): 1-12
标识
DOI:10.3892/ol.2026.15667
摘要

Recent neoadjuvant trials in lung cancer have demonstrated meaningful survival advantages, highlighting the need for standardized assessment of pathologic response in resected specimens. Only two systems are currently recommended for evaluating post-treatment response, namely the International Association for the Study of Lung Cancer (IASLC) tumor regression grading system and the immune-related pathologic response criteria (irPRC). The present study aimed to review and apply histopathologic parameters for assessing tumor regression in non-small cell lung carcinoma (NSCLC) specimens resected after neoadjuvant therapy. A total of 30 NSCLC resections obtained after neoadjuvant therapy between 2022 and 2025 were analyzed. Gross and microscopic evaluations were performed according to IASLC recommendations. Residual viable tumor, fibrosis, inflammation and necrosis were semi-quantitatively assessed according to IASLC and irPRC principles. Major pathologic response (mPR) was defined as ≤10% viable tumor and pathologic complete response (pCR) as 0% viable tumor. Associations with demographic features, treatment modalities and survival outcomes were analyzed. Compared with chemotherapy (CT) alone, chemo-immunotherapy (CIT) exhibited a trend toward a deeper pattern of tumor regression, reflected by lower median viable tumor percentages (7.5 vs. 55.0%) and higher mPR rates (62.5 vs. 22.7%), although these differences did not reach statistical significance. pCR occurred in 37.5% of patients treated with CIT and in 13.6% of patients treated with CT. CIT specimens demonstrated more prominent immune-mediated stromal changes, including greater intratumoral inflammation (32.5 vs. 10.0%) and more frequent lymphocytic patterns. Fibrosis strongly correlated with response (P<0.001), whereas necrosis did not. Spread through air spaces positivity was found to be significantly reduced in cases of mPR (P<0.001). Therefore, neoadjuvant CIT may be associated with deeper pathologic regression compared with CT, characterized by increased fibrosis and immune activation. Major pathologic response remains a potential prognostic indicator and integration of IASLC and irPRC criteria, together with tumor microenvironment assessment, may improve the evaluation of treatment response in resectable NSCLC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
刚刚
刚刚
刚刚
刚刚
刚刚
1秒前
1秒前
1秒前
xxddbb完成签到,获得积分10
1秒前
昏睡的思天完成签到 ,获得积分10
1秒前
lei完成签到 ,获得积分10
2秒前
2秒前
2秒前
3秒前
斯文败类的应助被俭朴钢铁侠采纳,获得10
3秒前
luo完成签到 ,获得积分10
3秒前
Shuang发布了新的文献求助10
3秒前
李妍发布了新的文献求助20
3秒前
chenxiangke完成签到 ,获得积分10
4秒前
4秒前
难过丹寒发布了新的文献求助10
4秒前
MADAO发布了新的文献求助30
4秒前
4秒前
星辰大海的应助被机灵幻天采纳,获得10
5秒前
皆辰发布了新的文献求助10
6秒前
詹慧子发布了新的文献求助10
6秒前
6秒前
7秒前
拾玖完成签到,获得积分10
8秒前
豆腐干地方完成签到,获得积分10
8秒前
8秒前
9秒前
li发布了新的文献求助10
9秒前
胡渊博发布了新的文献求助10
9秒前
10秒前
安静发布了新的文献求助10
11秒前
小骄傲完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181888
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818887
捐赠科研通 7778145
什么是DOI,文献DOI怎么找? 3433528
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621